171 related articles for article (PubMed ID: 23267013)
1. The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain.
Beisner DR; Langerak P; Parker AE; Dahlberg C; Otero FJ; Sutton SE; Poirot L; Barnes W; Young MA; Niessen S; Wiltshire T; Bodendorf U; Martoglio B; Cravatt B; Cooke MP
J Exp Med; 2013 Jan; 210(1):23-30. PubMed ID: 23267013
[TBL] [Abstract][Full Text] [Related]
2. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain.
Schneppenheim J; Dressel R; Hüttl S; Lüllmann-Rauch R; Engelke M; Dittmann K; Wienands J; Eskelinen EL; Hermans-Borgmeyer I; Fluhrer R; Saftig P; Schröder B
J Exp Med; 2013 Jan; 210(1):41-58. PubMed ID: 23267015
[TBL] [Abstract][Full Text] [Related]
3. Substrate determinants of signal peptide peptidase-like 2a (SPPL2a)-mediated intramembrane proteolysis of the invariant chain CD74.
Hüttl S; Helfrich F; Mentrup T; Held S; Fukumori A; Steiner H; Saftig P; Fluhrer R; Schröder B
Biochem J; 2016 May; 473(10):1405-22. PubMed ID: 26987812
[TBL] [Abstract][Full Text] [Related]
4. B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A.
Bergmann H; Yabas M; Short A; Miosge L; Barthel N; Teh CE; Roots CM; Bull KR; Jeelall Y; Horikawa K; Whittle B; Balakishnan B; Sjollema G; Bertram EM; Mackay F; Rimmer AJ; Cornall RJ; Field MA; Andrews TD; Goodnow CC; Enders A
J Exp Med; 2013 Jan; 210(1):31-40. PubMed ID: 23267016
[TBL] [Abstract][Full Text] [Related]
5. Signal-peptide-peptidase-like 2a is required for CD74 intramembrane proteolysis in human B cells.
Schneppenheim J; Hüttl S; Kruchen A; Fluhrer R; Müller I; Saftig P; Schneppenheim R; Martin CL; Schröder B
Biochem Biophys Res Commun; 2014 Aug; 451(1):48-53. PubMed ID: 25035924
[TBL] [Abstract][Full Text] [Related]
6. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
[TBL] [Abstract][Full Text] [Related]
7. The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo.
Schneppenheim J; Hüttl S; Mentrup T; Lüllmann-Rauch R; Rothaug M; Engelke M; Dittmann K; Dressel R; Araki M; Araki K; Wienands J; Fluhrer R; Saftig P; Schröder B
Mol Cell Biol; 2014 Apr; 34(8):1398-411. PubMed ID: 24492962
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of the Intramembrane Protease SPPL2a Alters Antimycobacterial Cytokine Responses of Dendritic Cells.
Gradtke AC; Mentrup T; Lehmann CHK; Cabrera-Cabrera F; Desel C; Okakpu D; Assmann M; Dalpke A; Schaible UE; Dudziak D; Schröder B
J Immunol; 2021 Jan; 206(1):164-180. PubMed ID: 33239420
[TBL] [Abstract][Full Text] [Related]
9. The intramembrane protease SPPL2A is critical for tooth enamel formation.
Bronckers AL; Gueneli N; Lüllmann-Rauch R; Schneppenheim J; Moraru AP; Himmerkus N; Bervoets TJ; Fluhrer R; Everts V; Saftig P; Schröder B
J Bone Miner Res; 2013 Jul; 28(7):1622-30. PubMed ID: 23426979
[TBL] [Abstract][Full Text] [Related]
10. The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments.
Schneppenheim J; Loock AC; Hüttl S; Schweizer M; Lüllmann-Rauch R; Oberg HH; Arnold P; Lehmann CHK; Dudziak D; Kabelitz D; Lucius R; Lennon-Duménil AM; Saftig P; Schröder B
J Immunol; 2017 Jul; 199(1):172-185. PubMed ID: 28550201
[TBL] [Abstract][Full Text] [Related]
11. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency.
Kong XF; Martinez-Barricarte R; Kennedy J; Mele F; Lazarov T; Deenick EK; Ma CS; Breton G; Lucero KB; Langlais D; Bousfiha A; Aytekin C; Markle J; Trouillet C; Jabot-Hanin F; Arlehamn CSL; Rao G; Picard C; Lasseau T; Latorre D; Hambleton S; Deswarte C; Itan Y; Abarca K; Moraes-Vasconcelos D; Ailal F; Ikinciogullari A; Dogu F; Benhsaien I; Sette A; Abel L; Boisson-Dupuis S; Schröder B; Nussenzweig MC; Liu K; Geissmann F; Tangye SG; Gros P; Sallusto F; Bustamante J; Casanova JL
Nat Immunol; 2018 Sep; 19(9):973-985. PubMed ID: 30127434
[TBL] [Abstract][Full Text] [Related]
12. Impaired proteolysis by SPPL2a causes CD74 fragment accumulation that can be recognized by anti-CD74 autoantibodies in human ankylosing spondylitis.
van Kempen TS; Leijten EFA; Lindenbergh MFS; Nordkamp MO; Driessen C; Lebbink RJ; Baerlecken N; Witte T; Radstake TRDJ; Boes M
Eur J Immunol; 2020 Aug; 50(8):1209-1219. PubMed ID: 32198923
[TBL] [Abstract][Full Text] [Related]
13. A Cell-Based Assay Reveals Nuclear Translocation of Intracellular Domains Released by SPPL Proteases.
Mentrup T; Häsler R; Fluhrer R; Saftig P; Schröder B
Traffic; 2015 Aug; 16(8):871-92. PubMed ID: 25824657
[TBL] [Abstract][Full Text] [Related]
14. Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).
Brady OA; Zhou X; Hu F
J Biol Chem; 2014 Jul; 289(28):19670-80. PubMed ID: 24872421
[TBL] [Abstract][Full Text] [Related]
15. Intramembrane proteolysis within lysosomes.
Schröder B; Saftig P
Ageing Res Rev; 2016 Dec; 32():51-64. PubMed ID: 27143694
[TBL] [Abstract][Full Text] [Related]
16. On the track of intramembrane clippers: the SPPL2a/b proteases caught in the act in animal models.
Trávníčková K; Stříšovský K
FEBS J; 2023 May; 290(9):2306-2310. PubMed ID: 36310421
[TBL] [Abstract][Full Text] [Related]
17. The intramembrane proteases SPPL2a and SPPL2b regulate the homeostasis of selected SNARE proteins.
Ballin M; Griep W; Patel M; Karl M; Mentrup T; Rivera-Monroy J; Foo B; Schwappach B; Schröder B
FEBS J; 2023 May; 290(9):2320-2337. PubMed ID: 36047592
[TBL] [Abstract][Full Text] [Related]
18. Signal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late endosomes by a tyrosine motif in its C-terminal tail.
Behnke J; Schneppenheim J; Koch-Nolte F; Haag F; Saftig P; Schröder B
FEBS Lett; 2011 Oct; 585(19):2951-7. PubMed ID: 21896273
[TBL] [Abstract][Full Text] [Related]
19. CD74 is a member of the regulated intramembrane proteolysis-processed protein family.
Becker-Herman S; Arie G; Medvedovsky H; Kerem A; Shachar I
Mol Biol Cell; 2005 Nov; 16(11):5061-9. PubMed ID: 16107560
[TBL] [Abstract][Full Text] [Related]
20. Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.
Mentrup T; Theodorou K; Cabrera-Cabrera F; Helbig AO; Happ K; Gijbels M; Gradtke AC; Rabe B; Fukumori A; Steiner H; Tholey A; Fluhrer R; Donners M; Schröder B
J Exp Med; 2019 Apr; 216(4):807-830. PubMed ID: 30819724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
